Step Pharma
Latest round
- Series C
Last raised
- Oct 2025
Total raised
- $61M
Investors
- 8
About Step Pharma
Step Pharma SAS, based in France, is a biotechnology company focused on developing innovative oncology therapies. Their primary product, dencatistat (STP938), is designed to treat various cancer types with targeted therapy. Founded in 2014 and headquartered in Paris, France, Step Pharma is dedicated to advancing cancer treatment through the development of specialized therapies. Step Pharma specializes in the development of innovative oncology therapies, with dencatistat (STP938) as their lead asset. This first-in-class, highly selective, and orally bioavailable targeted therapy aims to address several cancer types, including T Cell Lymphomas, B Cell Lymphomas, Solid Tumors, Essential Thrombocythaemia, and Autoimmune Diseases. By targeting specific pathways involved in cancer cell proliferation, dencatistat seeks to enhance existing treatment regimens.Step Pharma generates revenue through strategic partnerships and collaborations with healthcare institutions and pharmaceutical companies in the oncology sector. Their business model includes direct supply agreements with hospitals and clinics utilizing dencatistat and potentially other pipeline products. While specific pricing strategies for dencatistat have not been disclosed, their revenue approach underscores the significance of establishing partnerships that ensure access to their therapeutics for a broader patient population.
Who invested in Step Pharma
8 investors across 5 rounds
See all investors in Step Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Step Pharma
Who invested in Step Pharma?
Step Pharma has 8 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Step Pharma raised?
Step Pharma has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Step Pharma last raise money?
Step Pharma's most recent round on record is a Series C, in Oct 2025.
What does Step Pharma do?
Step Pharma SAS, based in France, is a biotechnology company focused on developing innovative oncology therapies.
Where is Step Pharma headquartered?
Step Pharma is headquartered in Paris, France.
Which VCs invest in companies like Step Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Step Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Step Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.